LARS1 and fungal infectious disease: Future developments in the field, including a better understanding of the interplay between CLRs and the mycobiota, as well as the influence of lifestyle, inflammatory microenvironment, notably with the collaboration of CLRs with other PRRs and cytokine receptors, and the role of endogenous ligand binding during fungal infections will eventually lead to the development of new antifungal therapeutic strategies.